Insider filing · URGN
Mark Schoenberg
Chief Medical Officer
profile →
UroGen Pharma Ltd.
URGN · Healthcare · 8 filings in 24 months
ticker →
Mark Schoenberg sold $400K of UroGen Pharma (URGN)
Executed Jul 9, disclosed Jul 10, 1 day later.
Value, as filed
$400K
10,000 sh × $40.00
Executed
Jul 9
the trade date, as filed
Disclosed
Jul 10
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MSMark Schoenberg (Chief Medical Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in UroGen Pharma Ltd. (URGN). The largest single filing was $2.9M of URGN (60,677 sh × $47.05, as filed), executed Aug 20.
The name
URGNHealthcare · UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty can…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mark Schoenberg in URGN
URGNSALE
UroGen Pharma Ltd.
$2.9M60,677 sh × $47.05
Exec Aug 20
Filed Aug 24 · 5:03 PM ET URGNSALE UroGen Pharma Ltd. $350K
10,000 sh × $35.01
Exec Jun 22
Filed Jun 24 · 5:30 PM ET URGNSALE UroGen Pharma Ltd. $143K
5,222 sh × $27.30
Exec Jun 8
Filed Jun 9 · 5:30 PM ET URGNSALE UroGen Pharma Ltd. $300K
10,000 sh × $30.00
Exec May 8
Filed May 11 · 5:30 PM ET URGNSALE UroGen Pharma Ltd. $250K
10,000 sh × $25.00
Exec Nov 19 2025
Filed Nov 20 2025 · 5:30 PM ET URGNSALE UroGen Pharma Ltd. $177K
10,000 sh × $17.69
Exec Aug 11 2025
Filed Aug 13 2025 · 5:30 PM ET